HEMAGEN DIAGNOSTICS INC
10KSB, EX-23, 2000-12-29
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: HEMAGEN DIAGNOSTICS INC, 10KSB, EX-10.31, 2000-12-29
Next: PRINCIPAL UTILITIES FUND INC /MD/, 485APOS, 2000-12-29



<PAGE>   1


EXHIBIT 23


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


Hemagen Diagnostics, Inc.
Columbia, Maryland

          We hereby consent to the incorporation by reference in the Prospectus
constituting a part of the Registration Statements on Form S-3 (Nos. 33-80009,
333-06147, 33-40606 and the Registration Statement on Form S-8 File No.
333-03718) of our report dated December 12, 2000, relating to the consolidated
financial statements of Hemagen Diagnostics, Inc. appearing in Hemagen's Annual
Report on Form 10-KSB for the year ended September 30, 2000. Our report contains
an explanatory paragraph regarding uncertainties as to the Company's ability to
continue in business.





                                           BDO Seidman, LLP



Washington D.C.
December 12, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission